戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 N primary because they were apparently cured postresection.
2 ning by FDG-PET is associated with excellent postresection 5-year overall survival for patients under
3  at western and eastern centers vary widely, postresection 5-year survival is similar when controllin
4                                              Postresection adaptation involves parallel changes in cr
5  death was the same across all sites 3 years postresection and decreased significantly for extremity/
6 study, disease-free patients at least 1 year postresection and gastric conduit reconstruction receive
7 ophagectomy (ES), n = 10, 2.4 +/- 0.75 years postresection; and unoperated control subjects, n = 8] w
8 extremity/trunk STS decreased by 40% 3 years postresection, but their influence over DSS for non-extr
9 tumor-catheter was resected en bloc, and the postresection cavity was treated with Ad-p53.
10     To identify new treatments we focused on postresection changes in microRNAs--short noncoding RNAs
11 ied how HFOs and spikes in combined pre- and postresection ECoG predict surgical outcome in different
12  ripples (80-250 Hz), and spikes in pre- and postresection ECoG sampled at 2,048 Hz in people with re
13  been used in patients who have a predicted (postresection) future liver remnant (FLR) volume less th
14 CA19-9 >/= 1,000 U/mL that does not decrease postresection have the worst prognosis, but the mechanis
15                                              Postresection, mean ex vivo radionuclide counts were hig
16 c colorectal carcinoma in the liver and that postresection MMP9 inhibition may be clinically benefici
17 resection predictive factors were absence of postresection morbidity, and T-stage 1-2 at the resectio
18                                              Postresection MR images were coregistered to the SPECT s
19                                      Using a postresection pancreatic adenocarcinoma nomogram, patien
20 ed the determinants of long-term survival in postresection pancreatic cancer patients, but the majori
21 ical model to long-term follow-up studies of postresection patients to investigate the factors involv
22                               After a median postresection period of 44 months, recurrence was observ
23                                   Additional postresection predictive factors were absence of postres
24  pancreatectomy for PNETs and to establish a postresection prognostic score.
25 f survival and were incorporated into a PNET postresection prognostic score.
26 ion, with the "safety net" of SLT in case of postresection recurrence.
27                        Improved education on postresection risk assessment and risk reduction is need
28 r <1.5 mm was an independent determinants of postresection survival in certain subgroups.
29 re rare pancreatic neoplasms associated with postresection survival longer than ductal adenocarcinoma
30 ains an important independent determinant of postresection survival.
31 lesions in the pancreatic head, have similar postresection survival.
32                                              Postresection, the expression of caspases and genes invo
33                                    By 1-week postresection, villus heights and crypt depths were incr
34 nant liver volume in patients with estimated postresection volumes of less than 25% appears to reduce
35 fresh-frozen plasma after the first 24 hours postresection) was higher in the non-PVE patients than t
36  between 1 and 5 micrometastases at 10 years postresection, when they escape growth restriction with
37 t approach - perioperative therapy, adjuvant postresection with either systemic or hepatic arterial i
38                                              Postresection wound bed fluorescence was significantly l

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。